Mettler Toledo International Inc (MTD) Return on Investment ROI from the third quarter of 2026 to third quarter of 2025 and for the year 2026, average high and low, overall ranking from Sep 30 2026 to Sep 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Mettler toledo International Inc   (NYSE: MTD)


Mettler Toledo International Inc's ROI from its third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Mettler Toledo International Inc's ROI in the third quarter of 2026?
Mettler toledo International Inc achieved a return on average invested assets (ROI) of 37.15 % in its third quarter of 2026, this is above MTD's average return on investment of 24.39%.
Mettler Toledo International Inc s investments during the 12 months ending in the third quarter of 2026 are valued at $2 billion

ROI has improved compared to 36.2% in the second quarter of 2026, due to net income growth.

Within the Healthcare sector 35 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2026 from 124 to 147.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Investment Change TTM 9.49 % 13.44 % 18.68 % 23 % 14.68 %
Y / Y Net Income Change TTM 11.77 % 9.14 % 39.47 % 87.4 % 295.11 %
Investment (TTM) in Millions 2,445 2,470 2,628 2,515 2,393
Return On Investment (TTM) 37.15 % 36.2 % 35.4 % 35.72 % 36.39 %
MTD's Overall Ranking # 147 # 124 # 23 # 72 #
Seq. Investment Change TTM 0.52 % 1.18 % 1.61 % 5.95 % 4.15 %
Seq. Net Income Change TTM 3.14 % 3.49 % 0.67 % 4 % 0.72 %
Net Income (TTM) in Millions 934 906 875 869 836

MTD Company Profile >> Back to MTD Roi Comparisons >> See Annual MTD Return On Investment



Return On Investment MTD's Ranking
Within: No.
Industry # 0
Sector # 36
Overall # 147

Return On Investment Statistics
High Average Low
41.47 %
24.39 %
1.77 %
(Dec 31 2024)  



  News about Mettler toledo International Inc Return on Investment ROI

Mettler Toledo's Long-Serving Board Chair Robert Spoerry to Retire, Prompting Evaluation of Financial Performance and Leadership Succession

December 14, 2023

Report: Mettler Toledo s Board Chair, Robert Spoerry, Announces Retirement
COLUMBUS, Ohio - Mettler-Toledo International Inc. (NYSE: MTD) announced the upcoming retirement of its long-serving Board Chair, Robert F. Spoerry, who will not stand for re-election at the annual meeting of shareholders on May 9th, 2024. Mr. Spoerry, who has been associated with Mettler-Toledo for 40 years, served as the CEO from 1993 to 2007 and as the Chair of the Board of Directors since 1998, shortly after its initial public offering (IPO). As he bids farewell to the company, Roland Diggelmann, an Independent Director of the Board, will be nominated as his successor.
This decision marks the end of an era for Mettler Toledo, as Mr. Spoerry has played a pivotal role in the company s growth and success over the years. As CEO, he led the company through significant milestones and challenges. Under his guidance, Mettler Toledo achieved remarkable financial performance and established its reputation as a leading global provider of precision instruments and services.





Financial Statements
Mettler Toledo International Inc's III. Quarter Investments $ 2,445 Millions MTD's Balance sheet
Mettler Toledo International Inc's III. Quarter Income $ 246 Millions Quarterly MTD's Income Statement
MTD's Income by Division See MTD's Income by Division


MTD Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 2,363 1,968 2,066 2,233 2,118
Y / Y Investment Growth 20.07 % -4.74 % -7.5 % 5.44 % 7.28 %
Net Income in Millions 869 863 789 873 769
Y / Y Net Income Growth 0.7 % 9.43 % -9.6 % 13.46 % 27.58 %
Annual Return On Investment 36.79 % 43.86 % 38.18 % 39.07 % 36.31 %


Annual Roi Comment
In the fiscal year 2025 ROI deteriorated to 36.79 %, despite net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Laboratory Analytical Instruments Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
MTD's Roi Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for MTD's Competitors
Subscribers only: Roi for Mettler Toledo International Inc's Suppliers
Subscribers only: Return On Investment for MTD's Customers

Other Ratios
MTD's Roa MTD's Inventory Turnover Ratio MTD's Growth Rates MTD's Dividend Statistics
MTD's Profitability Ratios MTD's Asset Turnover Ratio MTD's Dividend Growth
MTD's Roe MTD's Valuation Ratios MTD's Financial Strength Ratios MTD's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2026, within Healthcare Sector ROI
Exelixis Inc   75.01 %
Ironwood Pharmaceuticals inc   68.68 %
Rigel Pharmaceuticals Inc  68.50 %
Alnylam Pharmaceuticals Inc   63.14 %
Idexx Laboratories Inc  52.51 %
Aurinia Pharmaceuticals Inc   45.04 %
Nurix Therapeutics Inc   44.12 %
Medpace Holdings Inc   41.14 %
Rallybio Corporation  36.04 %
Eli Lilly And Company  32.00 %
Caredx Inc   30.65 %
Zevra Therapeutics Inc   29.88 %
Acadia Pharmaceuticals Inc   26.89 %
Standard Biotools Inc   23.91 %
Iradimed Corporation  22.98 %
Corcept Therapeutics Inc  22.08 %
Resmed Inc   21.10 %
Alector Inc   20.83 %
Chemed Corporation  20.46 %
Halozyme Therapeutics Inc   19.64 %
Pro dex Inc   19.11 %
Dexcom Inc   18.92 %
Illumina Inc   18.74 %
Denali Therapeutics Inc   17.88 %
West Pharmaceutical Services Inc   17.65 %
Healthcare Services Group Inc   17.18 %
Neurocrine Biosciences Inc   16.94 %
Krystal Biotech Inc   16.91 %
Vertex Pharmaceuticals Inc  16.63 %
Intuitive Surgical Inc   16.30 %

Date modified: 2026-11-09T18:44:26+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.